Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327 pISSN 1738-1088

Cited by CrossRef (12)

  1. Micol Cuocina, Giuseppe Aiello, Pierfelice Cutrufelli, Martina Rampello, Laura Rapisarda, Alessandro Rodolico, Giuseppina Cantarella, Maria Salvina Signorelli, Renato Bernardini. Effect of N-acetylcysteine on craving in substance use disorders (SUD): a meta-analysis of randomized controlled trials. Front. Pharmacol. 2024;15
    https://doi.org/10.3389/fphar.2024.1462612
  2. Anton Shkundin, Angelos Halaris. IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions. JPM 2024;14:488
    https://doi.org/10.3390/jpm14050488
  3. Mona Singh, Alina Kim, Amelie Young, Deanna Nguyen, Cynthia L. Monroe, Tiffany Ding, Dennis Gray, Vishwanath Venketaraman. The Mechanism and Inflammatory Markers Involved in the Potential Use of N-acetylcysteine in Chronic Pain Management. Life 2024;14:1361
    https://doi.org/10.3390/life14111361
  4. Aakanksha Singh, Gurraj Singh, Satwant Singh, Sana Elham Kazi, Manpreet Gill. N-acetylcysteine in the Treatment of Internet Gaming Disorder. 2022
    https://doi.org/10.7759/cureus.28662
  5. Samer El Hayek, Nadine Koukach, Hossameldin Tolba, Wael Foad. Nutrition and Psychiatric Disorders. 2022.
    https://doi.org/10.1007/978-981-97-2681-3_18
  6. Emma L. Winterlind, Samantha G. Malone, Michael R. Setzer, Mikela A. Murphy, David Saunders, Joshua C. Gray. N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis. Addiction Biology 2024;29
    https://doi.org/10.1111/adb.70001
  7. Fateme Padoei, Peyman Mamsharifi, Pooya Hazegh, Homa Boroumand, Fatemeh Ostadmohammady, Samira Abbaszadeh‐Mashkani, Hamid Reza Banafshe, Amir Hassan Matini, Amir Ghaderi, Somayeh Ghadami Dehkohneh. The therapeutic effect of N‐acetylcysteine as an add‐on to methadone maintenance therapy medication in outpatients with substance use disorders: A randomized, double‐blind, placebo‐controlled clinical trial. Brain and Behavior 2023;13
    https://doi.org/10.1002/brb3.2823
  8. Shokouh Arjmand, Mehran Ilaghi, Mohammad Shafie’ei, Pedro H. Gobira, Rodrigo Grassi-Oliveira, Gregers Wegener. Exploring the potential link between ΔFosB and N-acetylcysteine in craving/relapse dynamics: can N-acetylcysteine stand out as a possible treatment candidate?. Acta Neuropsychiatr. 2024:1
    https://doi.org/10.1017/neu.2024.38
  9. Richard C. J. Bradlow, Michael Berk, Peter W. Kalivas, Sudie E. Back, Richard A. Kanaan. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. CNS Drugs 2022;36:451
    https://doi.org/10.1007/s40263-022-00907-3
  10. Ellen D. Herbst, David L. Pennington, Brian Borsari, Jennifer Manuel, Matthew Yalch, Eric Alcid, Madeline Martinez Rivas, Joannalyn Delacruz, Nathan Rossi, Brianna Garcia, Natalie Wong, Steven L. Batki. N-acetylcysteine for smoking cessation among dual users of tobacco and cannabis: Protocol and rationale for a randomized controlled trial. Contemporary Clinical Trials 2023;131:107250
    https://doi.org/10.1016/j.cct.2023.107250
  11. Seetal Dodd, Jodie Harper, Michael Berk. Current Pharmacotherapies for Smoking Cessation and Promising Emerging Drugs. CRCEP 2024;19:259
    https://doi.org/10.2174/0127724328274939231121114142
  12. Swati Sharma, Aishwarya Anand, Alka Bhatia, Vishal Sharma, Anupam K. Singh, Dibyajyoti Banerjee, Amol N. Patil. Pharmacological Evaluation of Scopoletin in the Carbon Tetrachloride- Induced Hepatotoxicity Model in Wistar Rats. 2022;14:201
    https://doi.org/10.4103/jpbs.jpbs_333_22